Published in Sci Rep on May 04, 2016
Persistent Persister Misperceptions. Front Microbiol (2016) 0.78
Fast gapped-read alignment with Bowtie 2. Nat Methods (2012) 83.79
Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol (2010) 39.63
Galaxy: a platform for interactive large-scale genome analysis. Genome Res (2005) 35.75
Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol (2010) 17.00
Bacterial persistence as a phenotypic switch. Science (2004) 15.80
Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep (2007) 11.94
Persister cells. Annu Rev Microbiol (2010) 7.24
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol (2004) 5.82
Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett (2004) 5.23
The viable but nonculturable state in bacteria. J Microbiol (2005) 4.52
Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality. J Bacteriol (1966) 4.08
Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature (2011) 4.06
Persisters: a distinct physiological state of E. coli. BMC Microbiol (2006) 4.03
A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat Methods (2006) 3.95
Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature (2013) 3.69
Dynamic persistence of antibiotic-stressed mycobacteria. Science (2013) 3.34
(p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell (2013) 3.28
Obg and Membrane Depolarization Are Part of a Microbial Bet-Hedging Strategy that Leads to Antibiotic Tolerance. Mol Cell (2015) 3.22
The sociobiology of biofilms. FEMS Microbiol Rev (2008) 3.19
Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol (2010) 3.12
Signaling-mediated bacterial persister formation. Nat Chem Biol (2012) 2.96
Nalidixic acid: an antibacterial paradox. Antimicrob Agents Chemother (1975) 2.94
The response regulator RssB controls stability of the sigma(S) subunit of RNA polymerase in Escherichia coli. EMBO J (1996) 2.91
The response regulator SprE controls the stability of RpoS. Proc Natl Acad Sci U S A (1996) 2.71
Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc Natl Acad Sci U S A (2008) 1.98
Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol (2011) 1.90
Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc Natl Acad Sci U S A (2012) 1.74
Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio (2011) 1.64
Metabolic control of persister formation in Escherichia coli. Mol Cell (2013) 1.62
Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother (2013) 1.51
Molecular mechanism of bacterial persistence by HipA. Mol Cell (2013) 1.48
Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol (2011) 1.47
Thirty years of Escherichia coli DNA gyrase: from in vivo function to single-molecule mechanism. Biochimie (2007) 1.47
Restoration of culturability of starvation-stressed and low-temperature-stressed Escherichia coli O157 cells by using H2O2-degrading compounds. Arch Microbiol (1999) 1.43
Cell division in Escherichia coli cultures monitored at single cell resolution. BMC Microbiol (2008) 1.41
Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother (2013) 1.33
Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli. FEMS Microbiol Lett (2009) 1.29
Not quite dead enough: on bacterial life, culturability, senescence, and death. Arch Microbiol (2001) 1.28
HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat Commun (2013) 1.26
Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet (2013) 1.23
The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J Bacteriol (2010) 1.22
Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr Opin Genet Dev (2011) 1.22
Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol Lett (2009) 1.20
Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrob Agents Chemother (2011) 1.19
Stochastic induction of persister cells by HipA through (p)ppGpp-mediated activation of mRNA endonucleases. Proc Natl Acad Sci U S A (2015) 1.10
Fluoroquinolones: mechanism of action, classification, and development of resistance. Surv Ophthalmol (2004) 1.07
Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of Escherichia coli. Antimicrob Agents Chemother (2006) 1.02
Economic burden of healthcare-associated infections: an American perspective. Expert Rev Pharmacoecon Outcomes Res (2009) 1.01
Antibacterial activity of ofloxacin and its mode of action. Infection (1986) 1.01
Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob Agents Chemother (2013) 1.00
Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli. BMC Microbiol (2013) 0.98
Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. PLoS One (2012) 0.98
MazF-induced growth inhibition and persister generation in Escherichia coli. J Biol Chem (2013) 0.94
Novel protocol for persister cells isolation. PLoS One (2014) 0.88
Persister Heterogeneity Arising from a Single Metabolic Stress. Curr Biol (2015) 0.85
Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics. Curr Opin Microbiol (2014) 0.85
Differential expression of the outer membrane protein W (OmpW) stress response in enterohemorrhagic Escherichia coli O157:H7 corresponds to the viable but non-culturable state. Res Microbiol (2008) 0.83
Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery. MBio (2015) 0.80
High-dose intravenous fluoroquinolones in the treatment of severe infections. J Chemother (1999) 0.77